| First Author | Hammad H | Year | 2000 |
| Journal | Lab Invest | Volume | 80 |
| Issue | 4 | Pages | 605-14 |
| PubMed ID | 10780676 | Mgi Jnum | J:61661 |
| Mgi Id | MGI:1355397 | Doi | 10.1038/labinvest.3780065 |
| Citation | Hammad H, et al. (2000) Human dendritic cells in the severe combined immunodeficiency mouse model: their potentiating role in the allergic reaction. Lab Invest 80(4):605-14 |
| abstractText | Dendritic cells (DCs) are present in the lungs and airways of healthy and allergic subjects where they are exposed to inhaled antigens. After the uptake of antigens, DCs migrate to lymphoid organs where T cells initiate and control the immune response. The migratory properties of DCs are an essential component of their function but remain unclear in the situation of allergic diseases. To better understand the role of DCs in response to allergens, we first investigated their presence in an original experimental model of allergic asthma: the humanized severe combined immunodeficiency (SCID) mouse reconstituted with peripheral blood mononuclear cells from patients sensitive to Dermatophagoides pteronyssinus (Dpt). Human DCs were detected in lungs of mice developing an inflammatory pulmonary infiltrate and appeared to be mainly located in the alveolar spaces. In a second step, human DCs were generated in vitro from monocytes and injected into naive SCID mice exposed or not exposed to Dpt aerosols. Their migratory behavior was explored, as well as their potential role in modulating the IgE production after exposure to Dpt. After exposure to Dpt, the number of DCs present in airways decreased, while it increased into the spleen and thymus of the mice. The IgE production increased in the presence of DCs as compared with mice not injected with DCs. These results suggest that DCs may play a role in the pulmonary allergic reaction developed in response to Dpt in SCID mice. |
